Screening for rectal cancer: will it improve cure rates?

Area of Science:

• Oncology
• Gastroenterology
• Preventive Medicine

Background:

• Colorectal cancer (CRC) remains a significant health concern.
• Effective screening strategies are crucial for early detection and improved outcomes.
• Rectal cancer diagnosis and management are key components of CRC screening.

Purpose of the Study:

• To provide an overview of current colorectal cancer screening strategies.
• To evaluate evidence for screening in both average-risk and high-risk populations.
• To emphasize the diagnosis and management of rectal cancer within screening contexts.

Main Methods:

• Review of published studies on CRC screening.
• Evaluation of evidence for various screening modalities (endoscopy, contrast studies, fecal occult blood testing).
• Analysis of screening guidelines for high-risk populations (history of CRC, IBD, inherited conditions).

Main Results:

• Biennial guaiac fecal occult blood testing reduces CRC-specific mortality by 15% in average-risk individuals.
• Flexible sigmoidoscopy reduces CRC-specific mortality by 50-80% in average-risk individuals.
• Screening strategies demonstrate higher sensitivity for distal colorectal lesions compared to proximal ones.

Conclusions:

• Colorectal cancer screening significantly reduces mortality in average-risk populations.
• Screening guidelines for high-risk groups are primarily based on case-control studies.
• Current screening methods show a bias towards detecting distal colorectal lesions.